Bristol-Myers Squibb was founded in 1858 and has grown ... Around the same time, the prototype of the Squibb logo was designed. The logo represented product uniformity, purity, efficacy and ...

(Reuters) — Bristol-Myers Squibb (BMY) on Sunday said it will acquire cancer drugmaker Mirati Therapeutics (MRTX) for up to $5.8 billion, diversifying its oncology business and adding drugs it ...

Shares of Bristol Myers Squibb Co. rose 3.83% to $45.81 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.41% to 5,916.93 and the ...

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology ...

Bristol Myers Squibb stock reversed higher Thursday after the drugmaker beat Wall Street's first-quarter expectations and raised its outlook for the year. Adjusted earnings came in at $1.80 per ...

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein 41 st Annual Strategic Decisions Conference on Wednesday, May 28, 2025. The company will take part ...

Aug 22 (Reuters) - Bristol-Myers Squibb-backed Zenas BioPharma has filed to go public in the United States, a regulatory filing showed on Thursday, underscoring improving investor appetite for new ...

2seventy and Bristol Myers Squibb currently share in U.S. commercialization of Abecma. Bristol Myers Squibb’s Opdualag paired with blockbuster immunotherapy Opdivo failed a clinical trial ...